Heart failure disease has been one of the major chronic cardiovascular diseases that cause morbidity, mortality, and hospitalization of all cardiac patients. Heart failure has a significantly increased lifetime risk of development is about 20%. Symptomatic predictions are usually non-specific and hardly can discriminate the occurrence of heart failure from other diseases. It represents a challenging problem because of its economical and medical burden on the health care system. However, the management and presentation of a patient with heart failure remain in the fields of doubt. This review will highlight the importance of diagnosing and managing Congestive heart failure patients for primary health care physicians. This review was collected and classified from eligible published English written documents, articles, clinical trials. This electronic research engine was included: PubMed. This review discussed the diagnosis and management of Congestive heart failure and the details regarding this topic including definitions classifications, were included in this review. The primary care physician approach is often concerned with traditional palliative therapies before worsening the condition and plans to assess different reports regarding heart failure patients throughout their follow-up schedules.

Background: The impact of on blood pressure (BP) and incidence of diabetes mellitus has not yet been elucidated. Therefore, the present study aimed to systematically discuss the prevalence of DM and hypertension in the published studies during the COVID-19 pandemic between 2019 and 2022 and compare these results with results reported in previous studies. Methodology: This was a comprehensive electronic systematic review that was time and language restricted. The search was conducted depending on different databases including PubMed, Google Scholar, Web of Science, and Cochrane library, for all studies published in the period between 2019 and 2022. Keywords used included COVID-19 OR SARS-CoV-2 OR Coronavirus OR “Corona virus” OR COVID, AND hypertension OR diabetes mellitus OR prevalence OR metabolic disorders AND cardiovascular conditions. The period of the study was chosen based on the fact that COVID-19 started in the beginning of 2019. Results: The primary search results of the current analysis ended in 875 hits which were reduced to 360 studies after removal of the duplicated studies. From those 360 studies, further evaluation for inclusion and exclusion criteria was conducted ending in 346 excluded studies. The reasons for exclusion included because of title and abstract (216 studies), being not relevant to the subject of the study (86 studies), being replies to authors (17 studies), books (2 topics), and being other reviews (26 studies). Finally , we included 13 studies in the qualitative synthesis of the current review. Conclusion: There was no significant increase in the prevalence of diabetes mellitus and hypertension among the general public in different regions of the world during the period of the COVID-19 pandemic compared with previous studies. Keywords: COVID-19, hypertension, diabetes mellitus